AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

OptimizeRx Corp Director's Dealing 2019

May 3, 2019

33090_dirs_2019-05-03_2954761f-49a3-4097-ad59-61f592759e07.zip

Director's Dealing

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: OptimizeRx Corp (OPRX)
CIK: 0001448431
Period of Report: 2019-04-29

Reporting Person: Silvestro Stephen L (Chief Commercial Officer)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common	0	Direct